#dermJC Transcript
Healthcare social media transcript of the #dermJC hashtag.
– ().
See #dermJC Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | Dermatology Journal Club @DermatologyJC Again, here is our paper for tonight (from @JAMADerm)! Some of the authors are on twitter - @DrMeganNoe @AMostaghimi @MishaRosenbach and @DanielButlerMD https://t.co/6cX3J4HEch #dermjc |
 | Arash Mostaghimi @AMostaghimi Hi Guys, thrilled that you are discussing our paper. Happy to answer questions. Coi unrelated, consult for Pfizer and Hims. #dermjc |
 | Dr. Carolyn Lee, MD/PhD @CarolynLeeMDPhD Hi, Cari Lee from Stanford derm. No COI. #dermjc |
 | Ade Adamson, MD MPP @AdeAdamson Dermatologist in Austin, Texas. I have no FCOI #dermJC |
 | Laleh Montaser Kouhsari, MD @llmontaseri Hi Laleh is here, pathology resident at Boston #dermjc |
 | Roxana Daneshjou MD/PhD @RoxanaDaneshjou What a great paper @AMostaghimi - Pyoderma gangrenosum is such a difficult entity; it was great to see a summary of data from this many cases. Was there a particular question you were seeking to answer? #dermjc |
 | Patrick Rush @DrPatrickRush Hi, Patrick from Virginia, no COI #dermjc |
 | Allison Larson, MD @AllisonLarsonMD Hi #DermJC. Allison joining from Boston |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: Hi Guys, thrilled that you are discussing our paper. Happy to answer questions. Coi unrelated, consult for Pfizer and Hims. #dermjc |
| Dermatology Journal Club @DermatologyJC #dermjc |
 | Leo Shmuylovich, MD PhD @leoshmu Hi #dermjc. Leo (peds derm fellow at Washu), joining for Saint Louis, no coi |
| Patrick Rush @DrPatrickRush In terms of the younger patients w/ IBD what was the breakdown for CD/UC was one more common? And Were most of them controlled or poorly controlled with their IBD? @AMostaghimi @DanielButlerMD #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou Note that this paper pointed out the importance of doing the skin biopsy when worried about pyoderma gangrenosum (instead of worrying about the pathergy). #dermjc |
| Dermatology Journal Club @DermatologyJC RT @DrPatrickRush: In terms of the younger patients w/ IBD what was the breakdown for CD/UC was one more common? And Were most of them controlled or poorly controlled with their IBD? @AMostaghimi @DanielButlerMD #dermjc |
 | Aaron Drucker @aaron_drucker Hi - Aaron in Toronto. No CoI. #dermjc |
| Patrick Rush @DrPatrickRush RT @RoxanaDaneshjou: Note that this paper pointed out the importance of doing the skin biopsy when worried about pyoderma gangrenosum (instead of worrying about the pathergy). #dermjc |
| Arash Mostaghimi @AMostaghimi RT @RoxanaDaneshjou: Note that this paper pointed out the importance of doing the skin biopsy when worried about pyoderma gangrenosum (instead of worrying about the pathergy). #dermjc |
| Patrick Rush @DrPatrickRush @RoxanaDaneshjou Yeah such as a small number had pathergy #DermJC |
| Patrick Rush @DrPatrickRush RT @DermatologyJC: #dermjc |
| Arash Mostaghimi @AMostaghimi @RoxanaDaneshjou Biopsy is important to rule out other diseases. In other work we've evaluated risk of pg after procedures. Low but not 0: 5.5% of procedures, 15.1% of patients. https://t.co/Z5yg8GDcSz #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @DrPatrickRush Yes! 28.1% of PG patients in this paper had pathergy. I'm going to quote that in the future. #dermjc |
| Patrick Rush @DrPatrickRush RT @AMostaghimi: @RoxanaDaneshjou Biopsy is important to rule out other diseases. In other work we've evaluated risk of pg after procedures. Low but not 0: 5.5% of procedures, 15.1% of patients. https://t.co/Z5yg8GDcSz #dermjc |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @RoxanaDaneshjou Biopsy is important to rule out other diseases. In other work we've evaluated risk of pg after procedures. Low but not 0: 5.5% of procedures, 15.1% of patients. https://t.co/Z5yg8GDcSz #dermjc |
| Patrick Rush @DrPatrickRush RT @RoxanaDaneshjou: @DrPatrickRush Yes! 28.1% of PG patients in this paper had pathergy. I'm going to quote that in the future. #dermjc |
 | David Harker, MD, FAAD @HarkerDavid @DermatologyJC Wish I could participate, but just got home from a busy day of hospital consults and gonna head to bed. I’ll look up the tweets tomorrow! #dermjc |
| Patrick Rush @DrPatrickRush @RoxanaDaneshjou Ditto #DermJC |
| Leo Shmuylovich, MD PhD @leoshmu #dermjc I couldn't tell if most of these patients got their PG diagnosis as an inpatient, or were admitted for complications of PG? Some of the worst PG patients I helped take care of on consults were well known and frequent flyers |
| Dr. Carolyn Lee, MD/PhD @CarolynLeeMDPhD @RoxanaDaneshjou I agree - pathergy occured less often than I expected! #dermjc |
| Patrick Rush @DrPatrickRush @lisa_iannattone I was wondering the same thing #DermJC |
 | Jules Lipoff, MD @juleslipoff Hi all #dermjc - I rarely can join these. No COI |
| Dermatology Journal Club @DermatologyJC RT @CarolynLeeMDPhD: @RoxanaDaneshjou I agree - pathergy occured less often than I expected! #dermjc |
| Patrick Rush @DrPatrickRush @juleslipoff Me either, this is my first one actually #dermJC |
| Aaron Drucker @aaron_drucker A question about the cancer diagnoses. Were a lot of these historical and taken out of the PMH section of the chart? If so, the older patients would have had more time to accrue them, hence the association with age #dermjc |
| Jules Lipoff, MD @juleslipoff Hey @AMostaghimi - maybe this is a silly question, but why did you pick 65 years old specifically as the demarcation between older and the rest? Is that a standard split? #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou Was there anything that surprised you @AMostaghimi @MishaRosenbach @DrMeganNoe @DanielButlerMD? #dermjc |
| Patrick Rush @DrPatrickRush @llmontaseri @juleslipoff Hey!!! 👋🏼 😁 #dermjc |
 | Sara Shalin @MightyDermPath RT @AMostaghimi: @RoxanaDaneshjou Biopsy is important to rule out other diseases. In other work we've evaluated risk of pg after procedures. Low but not 0: 5.5% of procedures, 15.1% of patients. https://t.co/Z5yg8GDcSz #dermjc |
| Leo Shmuylovich, MD PhD @leoshmu #dermjc cutaneous crohns can often be mistaken for PG - and getting Crohn's under control is key in those cases. In cases where cutaneous crohns was the comorbidity, was PG still the appropriate diagnosis? |
| Arash Mostaghimi @AMostaghimi @juleslipoff Hi @juleslipoff it's a great question. We did a sensitivity analysis showing that the association stayed the same whether it was 55, 65, or 75. Chose 65 as standard cutoff for older folks in US. #dermjc |
| Dermatology Journal Club @DermatologyJC RT @leoshmu: #dermjc cutaneous crohns can often be mistaken for PG - and getting Crohn's under control is key in those cases. In cases where cutaneous crohns was the comorbidity, was PG still the appropriate diagnosis? |
| Dermatology Journal Club @DermatologyJC RT @juleslipoff: Hey @AMostaghimi - maybe this is a silly question, but why did you pick 65 years old specifically as the demarcation between older and the rest? Is that a standard split? #dermjc |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @juleslipoff Hi @juleslipoff it's a great question. We did a sensitivity analysis showing that the association stayed the same whether it was 55, 65, or 75. Chose 65 as standard cutoff for older folks in US. #dermjc |
| Dermatology Journal Club @DermatologyJC RT @aaron_drucker: A question about the cancer diagnoses. Were a lot of these historical and taken out of the PMH section of the chart? If so, the older patients would have had more time to accrue them, hence the association with age #dermjc |
| Dermatology Journal Club @DermatologyJC RT @leoshmu: #dermjc I couldn't tell if most of these patients got their PG diagnosis as an inpatient, or were admitted for complications of PG? Some of the worst PG patients I helped take care of on consults were well known and frequent flyers |
| Patrick Rush @DrPatrickRush @RoxanaDaneshjou @AMostaghimi @MishaRosenbach @DrMeganNoe @DanielButlerMD Yeah, the low percentage of pathergy, as well as the stark age difference in the associated inflammatory diseases. I would have liked to see them touch on the type of IBD (CD/UC) &any relationship between well or poor symptomatic control of their IBD #dermjc |
| Arash Mostaghimi @AMostaghimi @aaron_drucker Hi @aaron_drucker spoken like a true epidemiologist. The cancer data was for either known active cancer or cancer dx in context of w/u for #pyoderma. UR correct that somebody may have had MGUS or something similar for a while beforehand so misattribution bias possible. #dermjc |
| Patrick Rush @DrPatrickRush RT @leoshmu: #dermjc cutaneous crohns can often be mistaken for PG - and getting Crohn's under control is key in those cases. In cases where cutaneous crohns was the comorbidity, was PG still the appropriate diagnosis? |
| Dr. Carolyn Lee, MD/PhD @CarolynLeeMDPhD I rarely initiate treatment for PG and would love to hear what others are using as first line treatment. Is it still oral steroids? #dermjc |
| Dermatology Journal Club @DermatologyJC #dermjc |
| Jules Lipoff, MD @juleslipoff @AMostaghimi Cool. Typical of the sort of kind of insightful but not really important comment I have to come up with when I'm asked to review your papers (oops unblinded, but not really unblinded) since they're so well thought out and put together. #dermjc |
| Arash Mostaghimi @AMostaghimi @DrPatrickRush @RoxanaDaneshjou @MishaRosenbach @DrMeganNoe @DanielButlerMD Hi @DrPatrickRush we couldn't correct for active versus not active IBD given retrospective study, but we did see that Crohns > UC in our population consistently across age. #dermjc https://t.co/2EG3Gook0S |
| Dermatology Journal Club @DermatologyJC RT @CarolynLeeMDPhD: I rarely initiate treatment for PG and would love to hear what others are using as first line treatment. Is it still oral steroids? #dermjc |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @aaron_drucker Hi @aaron_drucker spoken like a true epidemiologist. The cancer data was for either known active cancer or cancer dx in context of w/u for #pyoderma. UR correct that somebody may have had MGUS or something similar for a while beforehand so misattribution bias possible. #dermjc |
| Arash Mostaghimi @AMostaghimi @juleslipoff Kind of you @juleslipoff! Dermatology methodologies in general are behind many of our other medicine colleagues--better methods led by folks like @aaron_drucker should encourage all of us to raise our game. Multi-site retrospective is a start, prospective is better! #dermjc |
| Patrick Rush @DrPatrickRush RT @AMostaghimi: @DrPatrickRush @RoxanaDaneshjou @MishaRosenbach @DrMeganNoe @DanielButlerMD Hi @DrPatrickRush we couldn't correct for active versus not active IBD given retrospective study, but we did see that Crohns > UC in our population consistently across age. #dermjc https://t.co/2EG3Gook0S |
| Jules Lipoff, MD @juleslipoff Curious how people fall along lumper-splitter dichotomy when it comes to neutrophilic dermatoses - how much do we really believe that Sweet's is a completely different disease from PG, or are they different aspects of a continuum? How do Sweet's associations vary by age? #dermjc |
| Arash Mostaghimi @AMostaghimi @CarolynLeeMDPhD Hi @CarolynLeeMDPhD prednisone is fast, easy, and cheap but fantastic RCT from @CebdNottm of cyclosporine versus pred suggests that both good first line options for #pydoerma. https://t.co/ANQletJqQh #dermjc |
| Arash Mostaghimi @AMostaghimi @leoshmu Hi @leoshmu this can definitely be challenging to differentiate, but if I recall correctly I don't think any of our cases had cutaneous crohns + PG. If there were some it wasn't a large enough number to move results. #dermjc |
| Arash Mostaghimi @AMostaghimi @DrPatrickRush @lisa_iannattone Hi @lisa_iannattone I am obliged to answer my old fellow's questions ;-). We didn't look at activity in this study but definitely occult disease fairly common--I have dx 3 in last 6 months alone. I'd scope even if ROS negative. #dermjc |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @DrPatrickRush @RoxanaDaneshjou @MishaRosenbach @DrMeganNoe @DanielButlerMD Hi @DrPatrickRush we couldn't correct for active versus not active IBD given retrospective study, but we did see that Crohns > UC in our population consistently across age. #dermjc https://t.co/2EG3Gook0S |
| Arash Mostaghimi @AMostaghimi @leoshmu Hi @leoshmu a mix. Most intense cases generally inpatient, but lots of patients less explosive and managed outpatient basis, remember even topical monotherapy with steroids an option for these patients: https://t.co/rzBM9tOjBm #dermjc |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @CarolynLeeMDPhD Hi @CarolynLeeMDPhD prednisone is fast, easy, and cheap but fantastic RCT from @CebdNottm of cyclosporine versus pred suggests that both good first line options for #pydoerma. https://t.co/ANQletJqQh #dermjc |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @DrPatrickRush @lisa_iannattone Hi @lisa_iannattone I am obliged to answer my old fellow's questions ;-). We didn't look at activity in this study but definitely occult disease fairly common--I have dx 3 in last 6 months alone. I'd scope even if ROS negative. #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou We get a number of pyoderma gangrenosum consults a year. I'm printing this out and carrying it with me (or taking a photo of it). #dermjc https://t.co/CRIn21UmRr |
 | Misha Rosenbach, MD @MishaRosenbach @RoxanaDaneshjou @AMostaghimi @DrMeganNoe @DanielButlerMD I’m surprised more people aren’t excited to tweet about #pyodermagangrenosum @DrStevenTChen we may need a #meded #tweetorial to accompany #dermjc (though I am late tonight bc of other #dermatology work, @DermHospitalist #dermsaveslives #inpatientdermatology!) |
 | Pathology @mvmd0908 RT @RoxanaDaneshjou: We get a number of pyoderma gangrenosum consults a year. I'm printing this out and carrying it with me (or taking a photo of it). #dermjc https://t.co/CRIn21UmRr |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist We need more derms on twitter. And I've been trying to get in contact with more hospitalists on twitter. #dermjc |
| Patrick Rush @DrPatrickRush @AMostaghimi @RoxanaDaneshjou @MishaRosenbach @DrMeganNoe @DanielButlerMD Ah yeah I guess that would be pretty difficult and time consuming to do retrospectively. Hmm, that’s so interesting, I wonder why so many more CD? Thoughts? #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist Of course, we also have plenty of people who lurk and read! Our impressions (number of times the tweets are seen) have been pretty high for #dermjc. |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @leoshmu Hi @leoshmu a mix. Most intense cases generally inpatient, but lots of patients less explosive and managed outpatient basis, remember even topical monotherapy with steroids an option for these patients: https://t.co/rzBM9tOjBm #dermjc |
 | Daniel Butler MD @DanielButlerMD @RoxanaDaneshjou @MishaRosenbach @AMostaghimi @DrMeganNoe @DrStevenTChen @DermHospitalist I’m lurking! #dermjc |
| Dermatology Journal Club @DermatologyJC RT @juleslipoff: Curious how people fall along lumper-splitter dichotomy when it comes to neutrophilic dermatoses - how much do we really believe that Sweet's is a completely different disease from PG, or are they different aspects of a continuum? How do Sweet's associations vary by age? #dermjc |
| Patrick Rush @DrPatrickRush RT @AMostaghimi: @juleslipoff Kind of you @juleslipoff! Dermatology methodologies in general are behind many of our other medicine colleagues--better methods led by folks like @aaron_drucker should encourage all of us to raise our game. Multi-site retrospective is a start, prospective is better! #dermjc |
| Jules Lipoff, MD @juleslipoff @AMostaghimi @MishaRosenbach That's what I was getting at. Our clinical classifications and categories were created before the modern molecular technique age. We can understand categories as phenotypes that may have the same or different genotypes, and optimal treatment for each may vary #dermjc |
| Patrick Rush @DrPatrickRush RT @AMostaghimi: @CarolynLeeMDPhD Hi @CarolynLeeMDPhD prednisone is fast, easy, and cheap but fantastic RCT from @CebdNottm of cyclosporine versus pred suggests that both good first line options for #pydoerma. https://t.co/ANQletJqQh #dermjc |
| Laleh Montaser Kouhsari, MD @llmontaseri @juleslipoff I wonder if there was any evaluation between clinical Dx of PG/others and pathological Dx in this study.or they were all slam-dunk cases #dermJC |
| Dermatology Journal Club @DermatologyJC RT @juleslipoff: @AMostaghimi @MishaRosenbach That's what I was getting at. Our clinical classifications and categories were created before the modern molecular technique age. We can understand categories as phenotypes that may have the same or different genotypes, and optimal treatment for each may vary #dermjc |
| Dermatology Journal Club @DermatologyJC RT @llmontaseri: @juleslipoff I wonder if there was any evaluation between clinical Dx of PG/others and pathological Dx in this study.or they were all slam-dunk cases #dermJC |
 | Steven Chen 陳持威, MD, MPH, MHPEd @DrStevenTChen Hi #dermjc. Sorry I’m late! No Coi. |
| Ade Adamson, MD MPP @AdeAdamson Misha telling all the secrets #dermJC |
| Dermatology Journal Club @DermatologyJC RT @AdeAdamson: Misha telling all the secrets #dermJC |
| Leo Shmuylovich, MD PhD @leoshmu @AMostaghimi So none of them were PG and then after derm consult reclassified as cutaneous crohns? #dermjc |
| Steven Chen 陳持威, MD, MPH, MHPEd @DrStevenTChen @MishaRosenbach @RoxanaDaneshjou @AMostaghimi @DrMeganNoe @DanielButlerMD @DermHospitalist Would love to! I’m actually discussing at #hospmed19 with the @SHMLive folks. Will be sure to plug this paper! #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @DrStevenTChen @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DermHospitalist @SHMLive Could you tell them about #dermjc and to join in? We would also be happy to discuss topics they're interested in. |
| Dr. Carolyn Lee, MD/PhD @CarolynLeeMDPhD What is the role of topical steroids and/or topical steroid-sparing agents in treating PG? I inherited a patient with a <1.5 cm bx-proven PG and was not impressed by the response to topicals; however, it zipped right up with prednisone! #dermjc |
| Patrick Rush @DrPatrickRush @RoxanaDaneshjou @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist I’ve been trying to push it here. But so far it’s a slow uptake.. I’ll get to em eventually #dermjc 😉 |
| Steven Chen 陳持威, MD, MPH, MHPEd @DrStevenTChen @MishaRosenbach @AMostaghimi @juleslipoff Agree! As I’ve gotten older and more mature (ha!), I’ve become more of a lumper and realized the treatments for many of these are similar. That said, it does make studying them harder when we’re using retrospective cohorts and data extraction. #dermjc |
| Jules Lipoff, MD @juleslipoff @AdeAdamson Only in derm do we have a disease called "pyoderma gangenosum" which is neither a pyoderma nor gangrenous. @MishaRosenbach #dermjc https://t.co/6geAAVNNpA |
| Arash Mostaghimi @AMostaghimi @MishaRosenbach @juleslipoff @MishaRosenbach @AdeAdamson #dermjc https://t.co/2YewyyXJaM |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @DrPatrickRush @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist We're just gonna have such an awesome tweetup at #AAD2019 and we're gonna post photos and everyone will have FOMO and join twitter! #dermjc |
| Dermatology Journal Club @DermatologyJC RT @juleslipoff: @AdeAdamson Only in derm do we have a disease called "pyoderma gangenosum" which is neither a pyoderma nor gangrenous. @MishaRosenbach #dermjc https://t.co/6geAAVNNpA |
| Dermatology Journal Club @DermatologyJC RT @DrStevenTChen: @MishaRosenbach @AMostaghimi @juleslipoff Agree! As I’ve gotten older and more mature (ha!), I’ve become more of a lumper and realized the treatments for many of these are similar. That said, it does make studying them harder when we’re using retrospective cohorts and data extraction. #dermjc |
| Dermatology Journal Club @DermatologyJC RT @CarolynLeeMDPhD: What is the role of topical steroids and/or topical steroid-sparing agents in treating PG? I inherited a patient with a <1.5 cm bx-proven PG and was not impressed by the response to topicals; however, it zipped right up with prednisone! #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush Do you ever find that a re-flare of PG indicates return of a malignancy when PG is malignancy-associated? #dermjc |
| Patrick Rush @DrPatrickRush @MishaRosenbach @AMostaghimi @juleslipoff Yeah but it all sounds so fancy. Fancy words makes it feels credible #dermjc https://t.co/LZ4iUerfaj |
| Arash Mostaghimi @AMostaghimi @RoxanaDaneshjou @MishaRosenbach @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush Fantastic question. Anecdotally yes, not evaluated in this paper. @MishaRosenbach I don't think I have enough of these patients outside of probably AML which is more Sweet's than PG. Do you? #dermjc |
| Dermatology Journal Club @DermatologyJC RT @RoxanaDaneshjou: @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush Do you ever find that a re-flare of PG indicates return of a malignancy when PG is malignancy-associated? #dermjc |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @RoxanaDaneshjou @MishaRosenbach @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush Fantastic question. Anecdotally yes, not evaluated in this paper. @MishaRosenbach I don't think I have enough of these patients outside of probably AML which is more Sweet's than PG. Do you? #dermjc |
| Ade Adamson, MD MPP @AdeAdamson RT @juleslipoff: @AdeAdamson Only in derm do we have a disease called "pyoderma gangenosum" which is neither a pyoderma nor gangrenous. @MishaRosenbach #dermjc https://t.co/6geAAVNNpA |
| Jules Lipoff, MD @juleslipoff @DrPatrickRush @MishaRosenbach @AMostaghimi I bet you like to pronounce centimeter as SONTO-meter also, huh? #dermjc |
| Daniel Butler MD @DanielButlerMD @RoxanaDaneshjou @MishaRosenbach @AMostaghimi @DrMeganNoe @DrStevenTChen @DermHospitalist @DrPatrickRush I don’t have enough patients to have a good answer to that, but age of the patient at time of onset or flare always heightens my malignancy concern #dermjc |
| Jules Lipoff, MD @juleslipoff @MishaRosenbach @RoxanaDaneshjou @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush Is that really the case? Or if there is a malignancy associated, are we more prone to then call it Sweet's rather than PG? #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @DrStevenTChen @MishaRosenbach @AMostaghimi @juleslipoff Just gonna throw it in here that the ABD just approved my 2+1, and I'm joining a comp sci lab that uses machine learning on large molecular/genetic/imaging datasets. So if there is ever a dataset you guys accumulate that needs that kind of analysis, happy to collaborate. #dermjc |
| Dermatology Journal Club @DermatologyJC RT @juleslipoff: @MishaRosenbach @RoxanaDaneshjou @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush Is that really the case? Or if there is a malignancy associated, are we more prone to then call it Sweet's rather than PG? #dermjc |
| Dermatology Journal Club @DermatologyJC RT @DanielButlerMD: @RoxanaDaneshjou @MishaRosenbach @AMostaghimi @DrMeganNoe @DrStevenTChen @DermHospitalist @DrPatrickRush I don’t have enough patients to have a good answer to that, but age of the patient at time of onset or flare always heightens my malignancy concern #dermjc |
| Arash Mostaghimi @AMostaghimi @MishaRosenbach @RoxanaDaneshjou @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush Secret for you @MishaRosenbach and both of my twitter followers when we first did our procedure & PG recurrence study goal was to understand site specific nature to explore this phenomenon. We were underpowered, but hopefully someday. Great, great question. #dermjc |
| Dr. Carolyn Lee, MD/PhD @CarolynLeeMDPhD @RoxanaDaneshjou @MishaRosenbach @DrPatrickRush @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist I would use that baby running away GIF that @AdeAdamson used to reply to @MishaRosenbach a while ago (which still makes me laugh) but @RoxanaDaneshjou didn't show me how to do that on Twitter. #dermjc |
| Arash Mostaghimi @AMostaghimi @MishaRosenbach @RoxanaDaneshjou @DrStevenTChen @juleslipoff Sadly I feel that @RoxanaDaneshjou's definition of large data set and yours @MishaRosenbach may be different but I love this anyhow. Roxana don't ruin his spirit. #dermjc |
| Dermatology Journal Club @DermatologyJC RT @AMostaghimi: @MishaRosenbach @RoxanaDaneshjou @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush Secret for you @MishaRosenbach and both of my twitter followers when we first did our procedure & PG recurrence study goal was to understand site specific nature to explore this phenomenon. We were underpowered, but hopefully someday. Great, great question. #dermjc |
| Patrick Rush @DrPatrickRush @MishaRosenbach @AMostaghimi @RoxanaDaneshjou @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist Sounds like a good idea #dermjc let’s see it |
| Jules Lipoff, MD @juleslipoff @DrPatrickRush @MishaRosenbach @AMostaghimi We need to resolve the Kaposi's pronunciation question. He was a person, a Hungarian dermatologist, who clearly pronounced his name one way, yet medical dictionaries list both ways as acceptable (yes I looked). I hope we as dermatologists are right with [Kap oh sees]! #dermjc |
| Laleh Montaser Kouhsari, MD @llmontaseri RT @juleslipoff: @DrPatrickRush @MishaRosenbach @AMostaghimi We need to resolve the Kaposi's pronunciation question. He was a person, a Hungarian dermatologist, who clearly pronounced his name one way, yet medical dictionaries list both ways as acceptable (yes I looked). I hope we as dermatologists are right with [Kap oh sees]! #dermjc |
| Patrick Rush @DrPatrickRush RT @RoxanaDaneshjou: @DrPatrickRush @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist We're just gonna have such an awesome tweetup at #AAD2019 and we're gonna post photos and everyone will have FOMO and join twitter! #dermjc |
| Dr. Carolyn Lee, MD/PhD @CarolynLeeMDPhD @AdeAdamson @RoxanaDaneshjou @MishaRosenbach @DrPatrickRush @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist That's the one! That baby is hilarious. Thanks @AdeAdamson! #dermjc |
| Dermatology Journal Club @DermatologyJC RT @juleslipoff: @DrPatrickRush @MishaRosenbach @AMostaghimi We need to resolve the Kaposi's pronunciation question. He was a person, a Hungarian dermatologist, who clearly pronounced his name one way, yet medical dictionaries list both ways as acceptable (yes I looked). I hope we as dermatologists are right with [Kap oh sees]! #dermjc |
| Patrick Rush @DrPatrickRush Got to go for the night, but it was fun #dermjc , great discussion. Maybe I’ll see you at #AAD2019 https://t.co/RkQZTXNm3X |
| Daniel Butler MD @DanielButlerMD One last thing, I thought it was interesting looking through all those charts, the morphological descriptions were all over the place. Is there truly anything morphologically that you all really hold onto for PG diagnosis?? #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @MishaRosenbach @DrPatrickRush @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist We should just have a #dermtwitter contest to see which program can get the most residents signed up and engaged by a certain data... I feel like Penn and Harvard have the advantage with the most faculty on twitter. #dermjc |
| Ade Adamson, MD MPP @AdeAdamson @RoxanaDaneshjou March 3rd? #dermJC |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @ArtyDom @MishaRosenbach @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist @DrPatrickRush And the rest of #medtwitter went running away from #dermjc... |
| Ade Adamson, MD MPP @AdeAdamson @RoxanaDaneshjou @MishaRosenbach @DrPatrickRush @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist You have to control for size of program #dermJC!!! |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou Since #dermjc is coming to an end, going to take this time to plug the #AAD2019 tweetup on Sunday March 3 at 11:30 AM after the plenary at the AAD Connection/Networking Lounge is on Level 2 (right below the plenary room). |
| Ade Adamson, MD MPP @AdeAdamson I feel like that's a reflection of a lot of #dermJC around the country...🤣 |
| Dermatology Journal Club @DermatologyJC RT @RoxanaDaneshjou: Since #dermjc is coming to an end, going to take this time to plug the #AAD2019 tweetup on Sunday March 3 at 11:30 AM after the plenary at the AAD Connection/Networking Lounge is on Level 2 (right below the plenary room). |
 | JAMA Dermatology @JAMADerm RT @DermatologyJC: Again, here is our paper for tonight (from @JAMADerm)! Some of the authors are on twitter - @DrMeganNoe @AMostaghimi @MishaRosenbach and @DanielButlerMD https://t.co/6cX3J4HEch #dermjc |
| Ade Adamson, MD MPP @AdeAdamson RT @RoxanaDaneshjou: Since #dermjc is coming to an end, going to take this time to plug the #AAD2019 tweetup on Sunday March 3 at 11:30 AM after the plenary at the AAD Connection/Networking Lounge is on Level 2 (right below the plenary room). |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @MishaRosenbach @DrPatrickRush @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist I learned a lot from the article, and I learned a lot from hearing from all of you. And now it's all on twitter... :) Will be posting impression stats in the future to show just how far each tweet reaches! #dermjc |
| Roxana Daneshjou MD/PhD @RoxanaDaneshjou @juleslipoff @MishaRosenbach @DrPatrickRush @AMostaghimi @DrMeganNoe @DanielButlerMD @DrStevenTChen @DermHospitalist I'm always happy to take article suggestions! I picked this one because I felt like I learned something and because PG is such a difficult diagnosis to make and manage. #dermjc |
#dermJC content from Twitter.